|
US4873191A
(en)
|
1981-06-12 |
1989-10-10 |
Ohio University |
Genetic transformation of zygotes
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4870009A
(en)
|
1982-11-22 |
1989-09-26 |
The Salk Institute For Biological Studies |
Method of obtaining gene product through the generation of transgenic animals
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4736866A
(en)
|
1984-06-22 |
1988-04-12 |
President And Fellows Of Harvard College |
Transgenic non-human mammals
|
|
JPS6147500A
(ja)
|
1984-08-15 |
1986-03-07 |
Res Dev Corp Of Japan |
キメラモノクロ−ナル抗体及びその製造法
|
|
EP0173494A3
(en)
|
1984-08-27 |
1987-11-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric receptors by dna splicing and expression
|
|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
|
JPS61134325A
(ja)
|
1984-12-04 |
1986-06-21 |
Teijin Ltd |
ハイブリツド抗体遺伝子の発現方法
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US5030559A
(en)
*
|
1986-04-01 |
1991-07-09 |
Board Of Regents, The University Of Texas System |
Methods and compositions for the identification of metastatic human tumors
|
|
EP0264166B1
(en)
|
1986-04-09 |
1996-08-21 |
Genzyme Corporation |
Transgenic animals secreting desired proteins into milk
|
|
US4902505A
(en)
|
1986-07-30 |
1990-02-20 |
Alkermes |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
|
US4987071A
(en)
|
1986-12-03 |
1991-01-22 |
University Patents, Inc. |
RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
|
|
US5116742A
(en)
|
1986-12-03 |
1992-05-26 |
University Patents, Inc. |
RNA ribozyme restriction endoribonucleases and methods
|
|
US4904582A
(en)
|
1987-06-11 |
1990-02-27 |
Synthetic Genetics |
Novel amphiphilic nucleic acid conjugates
|
|
US4873316A
(en)
|
1987-06-23 |
1989-10-10 |
Biogen, Inc. |
Isolation of exogenous recombinant proteins from the milk of transgenic mammals
|
|
US5162504A
(en)
|
1988-06-03 |
1992-11-10 |
Cytogen Corporation |
Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients
|
|
US5118611A
(en)
*
|
1988-07-25 |
1992-06-02 |
Adeza Biomedical Corporation |
Adenocarcinoma antigen binding methods and reagents
|
|
ATE151110T1
(de)
|
1988-09-02 |
1997-04-15 |
Protein Eng Corp |
Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5750373A
(en)
|
1990-12-03 |
1998-05-12 |
Genentech, Inc. |
Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants
|
|
FR2646438B1
(fr)
|
1989-03-20 |
2007-11-02 |
Pasteur Institut |
Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
|
|
US5328470A
(en)
|
1989-03-31 |
1994-07-12 |
The Regents Of The University Of Michigan |
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
|
|
US5459039A
(en)
|
1989-05-12 |
1995-10-17 |
Duke University |
Methods for mapping genetic mutations
|
|
ATE423195T1
(de)
|
1989-07-25 |
2009-03-15 |
Cell Genesys Inc |
Homologe rekombination für universelle donorzellen und chimerische säugetierzellen
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5393788A
(en)
|
1990-07-10 |
1995-02-28 |
Smithkline Beecham Corporation |
Phenylalkyl oxamides
|
|
WO1992020791A1
(en)
|
1990-07-10 |
1992-11-26 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
WO1992003918A1
(en)
|
1990-08-29 |
1992-03-19 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
CA2105300C
(en)
|
1991-03-01 |
2008-12-23 |
Robert C. Ladner |
Process for the development of binding mini-proteins
|
|
JP3672306B2
(ja)
|
1991-04-10 |
2005-07-20 |
ザ スクリップス リサーチ インスティテュート |
ファージミドを使用するヘテロ二量体受容体ライブラリー
|
|
DE4122599C2
(de)
|
1991-07-08 |
1993-11-11 |
Deutsches Krebsforsch |
Phagemid zum Screenen von Antikörpern
|
|
WO1993004169A1
(en)
|
1991-08-20 |
1993-03-04 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
|
US5605930A
(en)
|
1991-10-21 |
1997-02-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Compositions and methods for treating and preventing pathologies including cancer
|
|
US5965132A
(en)
*
|
1992-03-05 |
1999-10-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
|
US5428011A
(en)
|
1992-06-16 |
1995-06-27 |
Procyon Biopharma, Inc. |
Pharmaceutical preparations for inhibiting tumours associated with prostate adenocarcinoma
|
|
US5674682A
(en)
|
1992-10-29 |
1997-10-07 |
Thomas Jefferson University |
Nucleic acid primers for detecting micrometastasis of prostate cancer
|
|
US5547835A
(en)
|
1993-01-07 |
1996-08-20 |
Sequenom, Inc. |
DNA sequencing by mass spectrometry
|
|
GB9309966D0
(en)
|
1993-05-14 |
1993-06-30 |
Nordion Int Inc |
Detection of prostrate-specific antigen in breast tumors
|
|
US5723302A
(en)
*
|
1993-05-14 |
1998-03-03 |
Nordion International Inc. |
Detection of prostate-specific antigen in breast tumors
|
|
US6479055B1
(en)
*
|
1993-06-07 |
2002-11-12 |
Trimeris, Inc. |
Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
|
|
US5498531A
(en)
|
1993-09-10 |
1996-03-12 |
President And Fellows Of Harvard College |
Intron-mediated recombinant techniques and reagents
|
|
US5538848A
(en)
|
1994-11-16 |
1996-07-23 |
Applied Biosystems Division, Perkin-Elmer Corp. |
Method for detecting nucleic acid amplification using self-quenching fluorescence probe
|
|
EP0760006A1
(en)
*
|
1994-04-15 |
1997-03-05 |
The Trustees Of Columbia University In The City Of New York |
Method for molecular staging of prostate cancer
|
|
US5856112A
(en)
*
|
1994-06-16 |
1999-01-05 |
Urocor, Inc. |
Method for selectively inducing biomarker expression in urologic tumor tissue for diagnosis and treatment thereof
|
|
US5543994A
(en)
*
|
1995-02-27 |
1996-08-06 |
International Rectifier Corporation |
MOSFET driver with fault reporting outputs
|
|
US5635197A
(en)
|
1995-03-21 |
1997-06-03 |
Eli Lilly And Company |
Treatment and prevention of prostatic cancer metastasis
|
|
US5629007A
(en)
*
|
1995-03-21 |
1997-05-13 |
Eli Lilly And Company |
Method of preventing prostatic cancer development
|
|
US5633161A
(en)
*
|
1995-03-29 |
1997-05-27 |
Millennium Pharmaceuticals, Inc. |
Murine gene fomy030 coding for tumor progression inhibitor
|
|
US5882864A
(en)
*
|
1995-07-31 |
1999-03-16 |
Urocor Inc. |
Biomarkers and targets for diagnosis, prognosis and management of prostate disease
|
|
US5854206A
(en)
|
1995-08-25 |
1998-12-29 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of prostate cancer
|
|
GB9517779D0
(en)
|
1995-08-31 |
1995-11-01 |
Roslin Inst Edinburgh |
Biological manipulation
|
|
GB9517780D0
(en)
|
1995-08-31 |
1995-11-01 |
Roslin Inst Edinburgh |
Biological manipulation
|
|
US5905027A
(en)
*
|
1995-12-27 |
1999-05-18 |
Uab Research Foundation |
Method of diagnosing and treating gliomas
|
|
KR19990087802A
(ko)
|
1996-03-15 |
1999-12-27 |
길리스 스티브 |
전립선암의 면역치료 및 면역진단을 위한 화합물 및 방법
|
|
US5861248A
(en)
*
|
1996-03-29 |
1999-01-19 |
Urocor, Inc. |
Biomarkers for detection of prostate cancer
|
|
US5976838A
(en)
*
|
1996-12-18 |
1999-11-02 |
Genetics Institute, Inc. |
Secreted proteins and polynucleotides encoding them
|
|
US6887660B2
(en)
|
1997-02-25 |
2005-05-03 |
Corixa Corporation |
Compounds for immunodiagnosis of prostate cancer and methods for their use
|
|
PL196260B1
(pl)
|
1997-02-25 |
2007-12-31 |
Corixa Corp |
Polipeptyd, cząsteczka DNA, komórka gospodarza, białko fuzyjne, kompozycje farmaceutyczne i szczepionki do leczenia raka prostaty
|
|
EP0974652A4
(en)
|
1997-04-08 |
2000-08-30 |
Banyu Pharma Co Ltd |
GENE ASSOCIATED WITH CANCER METASTASE
|
|
WO1999018210A2
(en)
|
1997-10-07 |
1999-04-15 |
Corixa Corporation |
Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
|
|
AU734476B2
(en)
*
|
1997-11-05 |
2001-06-14 |
Baylor College Of Medicine |
Sequences for targeting metastatic cells
|
|
US6194186B1
(en)
*
|
1997-11-25 |
2001-02-27 |
Incyte Pharmaceuticals, Inc. |
Human protein kinase and kinase inhibitors
|
|
US5945522A
(en)
|
1997-12-22 |
1999-08-31 |
Genset |
Prostate cancer gene
|
|
US5972615A
(en)
*
|
1998-01-21 |
1999-10-26 |
Urocor, Inc. |
Biomarkers and targets for diagnosis, prognosis and management of prostate disease
|
|
EP1047793B1
(en)
|
1998-01-21 |
2006-11-15 |
Dianon Systems, Inc. |
Biomarkers and targets for diagnosis, prognosis and management of prostate disease
|
|
US6075182A
(en)
*
|
1998-02-13 |
2000-06-13 |
Pioneer Hi-Bred International, Inc. |
Soybean variety 93B53
|
|
US6476207B1
(en)
*
|
1998-06-11 |
2002-11-05 |
Chiron Corporation |
Genes and gene expression products that are differentially regulated in prostate cancer
|
|
AU4823599A
(en)
*
|
1998-06-22 |
2000-01-10 |
Incyte Pharmaceuticals, Inc. |
Prostate cancer-associated genes
|
|
EP1870466A3
(en)
|
1998-07-14 |
2008-03-19 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of prostate cancer
|
|
AU5810999A
(en)
*
|
1998-08-27 |
2000-03-21 |
Quark Biotech, Inc. |
Sequences characteristic of hypoxia-regulated gene transcription
|
|
WO2000014234A1
(en)
|
1998-09-08 |
2000-03-16 |
Urocor, Inc. |
Prostate specific promoter and regulation of gene expression
|
|
JP2002531061A
(ja)
|
1998-09-30 |
2002-09-24 |
ミレニアム ファーマシューティカルズ インク． |
前立腺癌の診断および治療において有用な特異的核酸およびポリペプチドの発現解析
|
|
EP1002862A1
(en)
*
|
1998-11-12 |
2000-05-24 |
Nitsch, Roger M., Prof. Dr. |
Methods of diagnosing or treating neurological diseases
|
|
US6355430B1
(en)
*
|
1998-12-24 |
2002-03-12 |
Millennium Pharmaceuticals, Inc. |
Diagnostic and screening methods employing KIAA0101
|
|
AU3395900A
(en)
*
|
1999-03-12 |
2000-10-04 |
Human Genome Sciences, Inc. |
Human lung cancer associated gene sequences and polypeptides
|
|
AU4484400A
(en)
*
|
1999-04-23 |
2000-11-10 |
University Of Washington |
Prostate-specific polynucleotides, polypeptides and their methods of use
|
|
JP4942127B2
(ja)
*
|
2000-02-25 |
2012-05-30 |
中外製薬株式会社 |
新規アルマジロリピート含有蛋白質、ａｌｅｘ１
|
|
IT1395574B1
(it)
|
2009-09-14 |
2012-10-16 |
Guala Dispensing Spa |
Dispositivo di erogazione
|